Möchten Sie immer auf dem neuesten Stand bleiben?

SELSKABSMEDDELELSE nr. 73 - 14. oktober 2024  Den 9. februar 2024 meddelte DFDS A/S (“DFDS”) iværksættelsen af et aktietilbage-købsprogram til gennemførsel i henhold til EUs...

COMPANY ANNOUNCEMENT no. 73 - 14 October 2024  On 9 February 2024, DFDS A/S (“DFDS”) announced the initiation of a share buyback programme to be executed in accordance with EU Market Abuse...

TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Barrick (NYSE:GOLD)(TSX:ABX) will release its Q3 2024 results on Thursday, November 7, 2024. President and CEO Mark Bristow will host a live presentation...

Ölgerðin Egill Skallagrímsson hf. mun birta árshlutauppgjör félagsins fyrir tímabilið 1. mars 2024 til 31. ágúst 2024, eftir lokun markaða fimmtudaginn 10. október 2024. Kynningarfundur vegna...

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The national nonprofit Older Adults Technology Services (OATS) from AARP is hosting a series of free digital literacy events for seniors in recognition of...

TOKYO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (NASDAQ: ELWS) ("Earlyworks" or the "Company"), a blockchain solution provider headquartered in Taito-ku, Tokyo which develops its...

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel...

Operational & Corporate Update Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the Brazilian focused gold mining and development company, is pleased to provide an...

Trial Design Showcased for the MIST Study, a Recently Initiated Phase 2b Clinical Trial, Evaluating the Efficacy and Safety of AP01 (inhaled pirfenidone) Compared to Placebo in Patients with...

BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...